Literature DB >> 11554166

Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.

L Langzam1, R Koren, R Gal, V Kugel, A Paz, A Farkas, S R Sampson.   

Abstract

We determined the pattern of protein kinase C (PKC) isoform expression in human cell lines by Western blotting and immunofluorescent staining techniques. In addition, we examined PKC isoform expression in tissue samples of transitional cell carcinoma (TCC) of the bladder. PKC delta, PKC beta II, and PKC eta were found primarily in the RT4 cell line (low-grade tumor), and PKC zeta was expressed most strongly in the SUP cell line (invasive tumor). In tissue samples of urinary bladder cancer, PKC isoenzymes were expressed differentially as a function of tumor stage and grade; expression of PKC beta II and PKC delta was high in normal tissue and in low-grade tumors and decreased with increasing stage and grade of TCC. The opposite pattern was seen with PKC zeta. The differences in expression of specific isoenzymes as related to levels of malignancy of the cell lines and tissue samples suggest that the PKC family has an important role in normal and neoplastic urothelium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554166     DOI: 10.1309/1VKK-HWH7-YVJN-7UF7

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

Review 1.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

2.  Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis.

Authors:  Bo Zhan; Chuize Kong; Zhe Zhang; Xiao Dong; Naiwen Zhang
Journal:  Exp Ther Med       Date:  2017-03-23       Impact factor: 2.447

3.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

4.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

5.  Protein kinase C beta in malignant pleural mesothelioma.

Authors:  Leonardo Faoro; Sivakumar Loganathan; Maria Westerhoff; Rahul Modi; Aliya N Husain; Maria Tretiakova; Tanguy Seiwert; Hedy L Kindler; Everett E Vokes; Ravi Salgia
Journal:  Anticancer Drugs       Date:  2008-10       Impact factor: 2.248

6.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

Review 7.  Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.

Authors:  Ling Huang; Senthil K Muthuswamy
Journal:  Curr Opin Genet Dev       Date:  2010-01-21       Impact factor: 5.578

8.  Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study.

Authors:  Vipin Yadav; Nicole C Yanez; Sarah E Fenton; Mitchell F Denning
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 9.  Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.

Authors:  Alexandra C Newton; John Brognard
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.